Description

HGH Fragment 176–191 is a synthetic peptide composed of amino acids 176 to 191 of the full human growth hormone (hGH) sequence. This specific segment has been engineered to retain the lipolytic activity of hGH while minimizing its effects on insulin resistance and IGF-1-mediated growth promotion.

Research indicates that Fragment 176–191 enhances the breakdown of adipose tissue by stimulating lipolysis and inhibiting lipogenesis, particularly in abdominal fat stores. Unlike intact hGH, this fragment does not significantly affect blood sugar levels or induce anabolic effects on muscle and bone, making it a targeted agent in experimental obesity and fat metabolism studies.

Its selective action has made it a compound of interest in research exploring fat loss, metabolic regulation, and body composition adjustments without the broader hormonal influence of full-length growth hormone. HGH Fragment 176–191 continues to be studied for its potential therapeutic applications in metabolic disorders and weight management.